The Hydroponics Company to outline ‘farm to pharma’ cannabis strategy at CEO Session
The Hydroponics Company Ltd’s (ASX:THC) vertically integrated ‘farm to pharma’ medicinal cannabis strategy will be outlined during the Proactive CEO Session in Sydney on Monday, October 22.
The company’s Medicinal Cannabis Division lead Andrew Beehag will make the presentation to investors.
He will also explain the reasons for the company’s intended name change to THC Global Group Limited.
do not advertise external links.au/...-cannabis-strategy-at-ceo-session-207038.html
October is here !, page-102
Add EPN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EPN (ASX) Chart |
Day chart unavailable